{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:06:11Z","timestamp":1791302771220,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/bmt.2016.211","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T13:47:48Z","timestamp":1471873668000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis"],"prefix":"10.1038","volume":"52","author":[{"given":"N","family":"Del Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Onida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Zaccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Saporiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Andracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Montemurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Mircoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"BFbmt2016211_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T . Scleroderma. N Engl J Med 2009; 360: 1989\u20132003.","journal-title":"N Engl J Med"},{"key":"BFbmt2016211_CR2","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/rheumatology\/keu285","volume":"54","author":"V Nagaraja","year":"2015","unstructured":"Nagaraja V, Denton CP, Khanna D . Old medications and new targeted therapies in systemic sclerosis. Rheumatology 2015; 54: 1944\u20131953.","journal-title":"Rheumatology"},{"key":"BFbmt2016211_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","volume":"13","author":"C Ferri","year":"2014","unstructured":"Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature. Autoimmun Rev 2014; 13: 1026\u20131034.","journal-title":"Autoimmun Rev"},{"key":"BFbmt2016211_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Landew\u00e9 R, Avouac J, Chwiesko S, Miniati I, Czirjak L et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009; 68: 620\u2013628.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2016211_CR5","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE et al. Scleroderma Lung Study Research Group. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655\u20132666.","journal-title":"N Engl J Med"},{"key":"BFbmt2016211_CR6","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54: 3962\u20133970.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2016211_CR7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","volume":"176","author":"DP Tashkin","year":"2007","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007; 176: 1026\u20131034.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt2016211_CR8","first-page":"RA187","volume":"16","author":"K Broad","year":"2010","unstructured":"Broad K, Pope JE . The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis. Med Sci Monit 2010; 16: RA187\u2013RA190.","journal-title":"Med Sci Monit"},{"key":"BFbmt2016211_CR9","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1186\/ar2534","volume":"10","author":"C Nannini","year":"2008","unstructured":"Nannini C, West CP, Erwin PJ, Matteson EL . Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008; 10: R124.","journal-title":"Arthritis Res Ther"},{"key":"BFbmt2016211_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","volume":"27","author":"A Young","year":"2015","unstructured":"Young A, Khanna D . Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014. Curr Opin Rheumatol 2015; 27: 241\u2013248.","journal-title":"Curr Opin Rheumatol"},{"key":"BFbmt2016211_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11926-013-0326-2","volume":"15","author":"K Naraghi","year":"2013","unstructured":"Naraghi K, van Laar JM . Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep 2013; 15: 326\u2013331.","journal-title":"Curr Rheumatol Rep"},{"key":"BFbmt2016211_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498\u2013506.","journal-title":"Lancet"},{"key":"BFbmt2016211_CR13","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490\u20132498.","journal-title":"JAMA"},{"key":"BFbmt2016211_CR14","unstructured":"ClinicalTrials.gov:Scleroderma: Cyclophosphamide or Transplantation (SCOT). Available at http:\/\/www.clinicaltrials.gov\/ct2\/show\/ NCT00114530?term=SCOT&rank=3. Accessed July 2015."},{"key":"BFbmt2016211_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581\u2013590.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2016211_CR16","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737\u20132747.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2016211_CR17","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892\u20131896.","journal-title":"J Rheumatol"},{"key":"BFbmt2016211_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901\u2013903.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2016211_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"TA Medsger","year":"2003","unstructured":"Medsger TA . Natural history of systemic sclerosis and the assessment of severity, functional state, and phychologic well-being. Rheum Dis Clin North Am 2003; 29: 255\u2013273.","journal-title":"Rheum Dis Clin North Am"},{"key":"BFbmt2016211_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bmt.2015.299","volume":"51","author":"MC Oliveira","year":"2016","unstructured":"Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplant 2016; 51: 501\u2013505.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016211_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.2009.127621","volume":"70","author":"RT Domsic","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr . Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011; 70: 104\u2013109.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2016211_CR22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/annrheumdis-2014-205226","volume":"74","author":"B Maurer","year":"2015","unstructured":"Maurer B, Graf N, Michel BA, M\u00fcller-Ladner U, Czirj\u00e1k L, Denton CP et al. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Ann Rheum Dis 2015; 74: 1124\u20131131.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2016211_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","volume":"381","author":"RK Burt","year":"2013","unstructured":"Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M et al. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet 2013; 381: 1116\u20131124.","journal-title":"Lancet"},{"key":"BFbmt2016211_CR24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/rheumatology\/kev117","volume":"54","author":"JM van Laar","year":"2015","unstructured":"van Laar JM, Naraghi K, Tyndall A . Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatology 2015; 54: 2126\u20132133.","journal-title":"Rheumatology"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016211","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:05:12Z","timestamp":1648062312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFbmt2016211"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.211","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"assertion":[{"value":"31 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}